We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+12.67%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$1.54T
AUM Growth
+$136B
Cap. Flow
+$2.01B
Cap. Flow %
0.13%
Top 10 Hldgs %
21.19%
Holding
8,401
New
313
Increased
3,923
Reduced
2,951
Closed
306

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$2.39B
2
NVDA icon
NVIDIA
NVDA
+$2.32B
3
MSFT icon
Microsoft
MSFT
+$2.06B
4
AAPL icon
Apple
AAPL
+$1.62B
5
BND icon
Vanguard Total Bond Market
BND
+$1.51B

Sector Composition

Rank Sector Weight
1 Technology 22.47%
2 Financials 11.66%
3 Consumer Discretionary 8.63%
4 Communication Services 7.31%
5 Healthcare 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCEL icon
5151
FuelCell Energy
FCEL
$1.72B
$693K ﹤0.01%
123,575
-16,252
-12% -$78.9K
AAAU icon
5152
Goldman Sachs Physical Gold ETF Shares
AAAU
$2.48B
$693K ﹤0.01%
21,208
+6,743
+47% +$219K
THM
5153
International Tower Hill Mines
THM
$500M
$691K ﹤0.01%
807,789
+384,476
+91% +$292K
KMTS
5154
Kestra Medical Technologies
KMTS
$1.34B
$690K ﹤0.01%
41,642
+36,854
+770% +$805K
UGL icon
5155
ProShares Ultra Gold
UGL
$661M
$690K ﹤0.01%
19,915
-163,085
-89% -$5.66M
PLG
5156
Platinum Group Metals
PLG
$162M
$689K ﹤0.01%
450,197
+231,618
+106% +$310K
USAR
5157
USA Rare Earth Inc
USAR
$3.65B
$688K ﹤0.01%
62,827
+56,022
+823% +$594K
ALLO icon
5158
Allogene Therapeutics
ALLO
$604M
$688K ﹤0.01%
608,969
-1,744,132
-74% -$2.32M
TSBK icon
5159
Timberland Bancorp
TSBK
$344M
$686K ﹤0.01%
21,991
+1,954
+10% +$59.5K
CLBR
5160
DELISTED
Colombier Acquisition Corp II
CLBR
$686K ﹤0.01%
44,380
+23,649
+114% +$310K
LAW icon
5161
CS Disco
LAW
$248M
$686K ﹤0.01%
157,002
+80,292
+105% +$315K
PLX icon
5162
Protalix BioTherapeutics
PLX
$193M
$684K ﹤0.01%
462,043
+378,485
+453% +$774K
TCX icon
5163
Tucows
TCX
$95.5M
$683K ﹤0.01%
34,643
-4,495
-11% -$80.5K
TNXP icon
5164
Tonix Pharmaceuticals
TNXP
$165M
$681K ﹤0.01%
18,928
+16,251
+607% +$426K
OTLK icon
5165
Outlook Therapeutics
OTLK
$198M
$681K ﹤0.01%
425,599
+386,125
+978% +$616K
MBCN
5166
DELISTED
Middlefield Banc Corp
MBCN
$679K ﹤0.01%
22,565
+9,375
+71% +$261K
ARB icon
5167
AltShares Merger Arbitrage ETF
ARB
$102M
$679K ﹤0.01%
23,829
-1,786
-7% -$50.4K
IMRX icon
5168
Immuneering
IMRX
$282M
$678K ﹤0.01%
201,094
-266,132
-57% -$456K
HLLY icon
5169
Holley
HLLY
$319M
$677K ﹤0.01%
338,614
-183,257
-35% -$389K
JHS
5170
John Hancock Income Securities Trust
JHS
$127M
$677K ﹤0.01%
59,985
-11,607
-16% -$130K
ONIT
5171
Onity Group
ONIT
$336M
$674K ﹤0.01%
17,662
+5,239
+42% +$185K
MTBA icon
5172
Simplify MBS ETF
MTBA
$1.53B
$672K ﹤0.01%
13,412
+1,431
+12% +$71.3K
REFI
5173
Chicago Atlantic Real Estate Finance
REFI
$255M
$671K ﹤0.01%
48,063
-13,611
-22% -$195K
GAU
5174
Galiano Gold
GAU
$478M
$669K ﹤0.01%
527,095
+367,157
+230% +$499K
NOA
5175
North American Construction
NOA
$376M
$668K ﹤0.01%
41,777
-5,944
-12% -$96.7K

Similar funds

Morgan Stanley's Q2 2025 Portfolio in Review

As of Q2 2025, Morgan Stanley held 8,401 positions worth $1.54T, up 9.8% from $1.4T the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Morgan Stanley's Q2 2025 filing shows 313 new, 3,923 increased, 2,951 reduced and 306 closed positions. Its largest new stake was JBS N.V.: 7,554,358 shares worth $110M. The largest sale was UnitedHealth, an estimated $2.39B.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2025 buy was JBS N.V.: 7,554,358 shares worth $110M.
  • Morgan Stanley added most to Vanguard Short-Term Bond ETF in Q2 2025, an estimated $1.77B increase.
  • Morgan Stanley's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $2.39B.
  • Morgan Stanley fully exited Discover Financial Services in Q2 2025, selling an estimated $786M.
  • Morgan Stanley's ten largest holdings make up 21% of its $1.54T portfolio in Q2 2025.
  • Morgan Stanley opened 313 new positions and closed 306 in Q2 2025.
  • Morgan Stanley's portfolio value rose 9.8% quarter-over-quarter to $1.54T.

Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.